Life-Threatening Primary Varicella Zoster Virus Infection With Hemophagocytic Lymphohistiocytosis-Like Disease in GATA2 Haploinsufficiency Accompanied by Expansion of Double Negative T-Lymphocytes
Seraina Prader, Matthias Felber, Benjamin Volkmer, Johannes Trück, Agnes Schwieger-Briel, Martin Theiler, Lisa Weibel, Sophie Hambleton, Katja Seipel, Stefano Vavassori, Jana Pachlopnik Schmid, Seraina Prader, Matthias Felber, Benjamin Volkmer, Johannes Trück, Agnes Schwieger-Briel, Martin Theiler, Lisa Weibel, Sophie Hambleton, Katja Seipel, Stefano Vavassori, Jana Pachlopnik Schmid
Abstract
Two unrelated patients with GATA2-haploinsufficiency developed a hemophagocytic lymphohistiocytosis (HLH)-like disease during a varicella zoster virus (VZV) infection. High copy numbers of VZV were detected in the blood, and the patients were successfully treated with acyclovir and intravenous immunoglobulins. After treatment with corticosteroids for the HLH, both patients made a full recovery. Although the mechanisms leading to this disease constellation have yet to be characterized, we hypothesize that impairment of the immunoregulatory role of NK cells in GATA2-haploinsufficiency may have accentuated the patients' susceptibility to HLH. Expansion of a double negative T-lymphocytic population identified with CyTOF could be a further factor contributing to HLH in these patients. This is the first report of VZV-triggered HLH-like disease in a primary immunodeficiency and the third report of HLH in GATA2-haploinsufficiency. Since HLH was part of the presentation in one of our patients, GATA2-haploinsufficiency represents a potential differential diagnosis in patients presenting with the clinical features of HLH-especially in cases of persisting cytopenia after recovery from HLH.
Keywords: GATA2 deficiency; NK cell abnormalities; TCRγδ T cells; hemophagocytic lymphohistiocytosis; primary immumunodeficiencies; varicella-zoster virus.
Figures
References
- Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, et al. . Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood (2011) 118:2653–5. 10.1182/blood-2011-05-356352
- Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et al. . GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood (2014) 123:809–21. 10.1182/blood-2013-07-515528
- Simonis A, Fux M, Nair G, Mueller NJ, Haralambieva E, Pabst T, et al. . Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature. Ann Hematol. (2018) 97:1961–73. 10.1007/s00277-018-3388-4
- Brooks EG, Schmalstieg FC, Wirt DP, Rosenblatt HM, Adkins LT, Lookingbill DP, et al. . A novel X-linked combined immunodeficiency disease. J Clin Invest. (1990) 86:1623–31. 10.1172/JCI114884
- Schmalstieg FC, Leonard WJ, Noguchi M, Berg M, Rudloff HE, Denney RM, et al. . Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. J Clin Invest. (1995) 95:1169–73. 10.1172/JCI117765
- Dobbs K, Domínguez Conde C, Zhang SY, Parolini S, Audry M, Chou J, et al. . Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections. N Engl J Med. (2015) 372:2409–22. 10.1056/NEJMoa1413462
- Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. . Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. (2009) 361:2046–55. 10.1056/NEJMoa0905506
- Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramírez-Alejo N, Kilic SS, et al. . Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. (2015) 212:1641–62. 10.1084/jem.20140280
- Roesler J, Kofink B, Wendisch J, Heyden S, Paul D, Friedrich W, et al. . Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol. (1999) 27:1368–74. 10.1016/S0301-472X(99)00077-6
- Etzioni A, Eidenschenk C, Katz R, Beck R, Casanova JL, Pollack S. Fatal varicella associated with selective natural killer cell deficiency. J Pediatr. (2005) 146:423–5. 10.1016/j.jpeds.2004.11.022
- Mace EM, Orange JS. Genetic causes of human NK cell deficiency and their effect on NK cell subsets. Front Immunol. (2016) 7:545. 10.3389/fimmu.2016.00545
- Ogunjimi B, Zhang SY, Sørensen KB, Skipper KA, Carter-Timofte M, Kerner G, et al. . Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J Clin Invest. (2017) 127:3543–56. 10.1172/JCI92280
- Biron CA, Byron KS, Sullivanm JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. (1989) 320:1731–5. 10.1056/NEJM198906293202605
- Mace EM, Hsu AP, Monaco-Shawver L, Makedonas G, Rosen JB, Dropulic L, et al. . Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood (2013) 121:2669–77. 10.1182/blood-2012-09-453969
- Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. . HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2007) 48:124–31. 10.1002/pbc.21039
- Faitelson Y, Grunebaum E. Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders. Clin Immunol. (2014) 155:118–25. 10.1016/j.clim.2014.09.008
- Bode SF, Ammann S, Al-Herz W, Bataneant M, Dvorak CC, Gehring S, et al. . The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica (2015) 100:978–88. 10.3324/haematol.2014.121608
- Spinner MA, Ker JP, Stoudenmire CJ, Fadare O, Mace EM, Orange JS, et al. . GATA2 deficiency underlying severe blastomycosis and fatal herpes simplex virus-associated hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. (2016) 137:638–40. 10.1016/j.jaci.2015.07.043
- Grossman J, Cuellar-Rodriguez J, Gea-Banacloche J, Zerbe C, Calvo K, Hughes T, et al. . Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biol Blood Marrow Transpl. (2014) 20:1940–8. 10.1016/j.bbmt.2014.08.004
- Cohen JI, Dropulic L, Hsu AP, Zerbe CS, Krogmann T, Dowdell K, et al. . Association of GATA2 deficiency with severe primary epstein-barr virus (EBV) infection and EBV-associated Cancers. Clin Infect Dis. (2016) 63:41–7. 10.1093/cid/ciw160
- van der Werff ten Bosch JE, Kollen WJ, Ball LM, Brinkman DM, Vossen AC, Lankester AC, et al. . Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2009) 53:226–8. 10.1002/pbc.22041
- Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood (2004) 104:735–43. 10.1182/blood-2003-10-3413
- Pachlopnik Schmid J, Ho CH, Chrétien F, Lefebvre JM, Pivert G, Kosco-Vilbois M, et al. . Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med. (2009) 1:112–24. 10.1002/emmm.200900009
- Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature (2011) 481:394–8. 10.1038/nature10624
- Lang PA, Lang KS, Xu HC, Grusdat M, Parish IA, Recher M, et al. . Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci USA. (2012) 109:1210–5. 10.1073/pnas.1118834109
- Sepulveda FE, Maschalidi S, Vosshenrich CA, Garrigue A, Kurowska M, Ménasche G, et al. . A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood (2015) 125:1427–34. 10.1182/blood-2014-09-602946
- Schlums H, Jung M, Han H, Theorell J, Bigley V, Chiang SC, et al. . Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells. Blood (2017) 129:1927–39. 10.1182/blood-2016-08-734236
Source: PubMed